HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafal Suwinski Selected Research

carboxyaminoimidazole ribotide (CAIR)

1/2016Randomized clinical trial on 7-days-a-week post-operative radiotherapy vs concurrent post-operative radiochemotherapy in locally advanced cancer of the oral cavity/oropharynx: a report on acute normal tissue reactions.
3/2013Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
1/2012PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.
5/2011Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer.
6/2010Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
11/2006Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
10/2005Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafal Suwinski Research Topics

Disease

9Neoplasms (Cancer)
05/2021 - 06/2003
5Head and Neck Neoplasms (Head and Neck Cancer)
05/2011 - 06/2003
3Brain Neoplasms (Brain Tumor)
12/2021 - 04/2021
3Mucositis
03/2013 - 10/2005
3Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2012 - 06/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 05/2021
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2021 - 04/2007
2Squamous Cell Carcinoma of Head and Neck
03/2013 - 11/2006
2Neoplasm Metastasis (Metastasis)
04/2007 - 06/2003
1Oropharyngeal Neoplasms
12/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Lung Neoplasms (Lung Cancer)
01/2012
1Papillomavirus Infections
05/2011
1Laryngeal Neoplasms (Laryngeal Cancer)
11/2007
1Rectal Neoplasms (Rectal Cancer)
11/2007
1Stomach Neoplasms (Stomach Cancer)
02/2007
1Necrosis
11/2006
1Body Weight (Weight, Body)
10/2005
1Erythema
10/2005
1Anemia
11/2004
1Urinary Bladder Neoplasms (Bladder Cancer)
09/2004
1Margins of Excision
06/2003

Drug/Important Bio-Agent (IBA)

7carboxyaminoimidazole ribotide (CAIR)IBA
01/2016 - 10/2005
2Hemoglobins (Hemoglobin)IBA
11/2007 - 09/2004
1ErbB Receptors (EGF Receptor)IBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1Cyclin D1IBA
01/2012
1RNA (Ribonucleic Acid)IBA
01/2012
1Messenger RNA (mRNA)IBA
01/2012
1Cyclin DIBA
05/2011
1ErythropoietinFDA Link
11/2004
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2004

Therapy/Procedure

18Radiotherapy
12/2021 - 06/2003
4Therapeutics
05/2021 - 06/2010
4Drug Therapy (Chemotherapy)
04/2021 - 04/2007
2Chemoradiotherapy
01/2016 - 02/2007
1Immunotherapy
05/2021
1Cranial Irradiation
04/2021
1Brachytherapy
01/2016
1Gastrectomy
02/2007
1Duration of Therapy
06/2003